The Impact of Supporting Family Caregivers Before Bereavement on Outcomes After Bereavement: Adequacy of End-of-Life Support and Achievement of Preferred Place of Death by Aoun, S et al.
Accepted Manuscript
The impact of supporting family caregivers pre-bereavement on outcomes post-
bereavement: Adequacy of end of life support and achievement of preferred place of
death
Samar M. Aoun, PhD, Gail Ewing, Gunn Grande, Chris Toye, Natasha Bear
PII: S0885-3924(17)30526-2
DOI: 10.1016/j.jpainsymman.2017.09.023
Reference: JPS 9600
To appear in: Journal of Pain and Symptom Management
Received Date: 1 May 2017
Revised Date: 21 September 2017
Accepted Date: 21 September 2017
Please cite this article as: Aoun SM, Ewing G, Grande G, Toye C, Bear N, The impact of supporting
family caregivers pre-bereavement on outcomes post-bereavement: Adequacy of end of life support
and achievement of preferred place of death, Journal of Pain and Symptom Management (2017), doi:
10.1016/j.jpainsymman.2017.09.023.
This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to
our customers we are providing this early version of the manuscript. The manuscript will undergo
copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please
note that during the production process errors may be discovered which could affect the content, and all
legal disclaimers that apply to the journal pertain.
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 
1 
 
The impact of supporting family caregivers pre-bereavement on outcomes post-
bereavement: Adequacy of end of life support and achievement of preferred place of 
death 
 
ABSTRACT  
 
Objectives: This study investigated the extent to which using the Carer Support Needs 
Assessment Tool (CSNAT) intervention during the caregiving period has affected bereaved 
family caregivers’ perceptions of adequacy of support, their grief and wellbeing and 
achievement of their preferred place of death. 
 
Method: All family caregivers who participated in a stepped wedge cluster trial of the CSNAT 
intervention in Western Australia (2012-14) and completed the pre-bereavement study 
(n=322) were invited to take part in a caregiver survey by telephone 4-6 months post-
bereavement (2015). The survey measured the adequacy of end of life support, the level of 
grief, the current physical and mental health, and the achievement of the preferred place of 
death. 
 
Results: The response rate was 66% (152, intervention; 60 control). The intervention group 
perceived their pre-bereavement support needs had been adequately met to a significantly 
greater extent than the control group (d=0.43, p<0.001) and that patients have achieved 
their preferred place of death more often according to their caregivers (79.6% vs 63.6%, 
p=0.034). There was also a greater agreement on the preferred place of death between 
patients and their caregivers in the intervention group (p=0.02). 
 
Conclusions: The results from this study provide evidence that the CSNAT intervention has a 
positive impact on perceived adequacy of support of bereaved family caregivers and 
achievement of preferred place of death according to caregivers. The benefits gained by 
caregivers in being engaged in early and direct assessment of their support needs pre-
bereavement, reinforces the need for palliative care services to effectively support 
caregivers well before the patient’s death. 
 
Keywords: CSNAT; Family caregivers; pre-bereavement; post-bereavement; place of death; 
grief; wellbeing; support needs. 
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BACKGROUND  
 
Two of the most stressful human experiences are caring for a person with a terminal illness 
and the death of that person. As the majority of deaths worldwide are currently caused by life 
limiting illnesses with a significant proportion of these deaths occurring in old age, the 
investigation of the situation of bereaved family caregivers following caregiving during the 
end-of-life phase of illness has not received enough attention (1).  
 
There is evidence to suggest that family caregivers who have cared for a relative/friend 
throughout a life-limiting illness are adversely affected during bereavement due to their 
caregiving role (2-5). Nielsen et al (6) reported that severe grief and depressive symptoms 
already existing before the patient’s death strongly predicted complicated grief and post-loss 
depressive symptoms. They also found that the levels of grief and depressive symptoms 
were higher during caregiving than six months after the loss.  
 
Studies have reported that reducing the burden of caregiving can prevent post-death 
psychiatric morbidity (3, 4), and that caregivers’ limited preparedness for the impending 
death was associated with increased complicated grief, depression and anxiety (7, 8). It has 
been suggested that surviving spouses of people admitted to a hospice have lower mortality 
compared to those whose spouses are not, due to hospice services preparing the family for 
the imminent death (9).  The extent to which caregivers are prepared or ready for the death 
of their family member comprises several dimensions: clinical, practical, psychosocial and 
spiritual (10). Communication between caregivers and health care professionals is crucial to 
aid preparedness in all these dimensions (7, 8). 
Other factors that may also impact on post-bereavement outcomes of family caregivers  are 
the location of death, the fulfilment of the patient’s or caregiver’s preferred place of death, or 
the perception that the place of death had been the right place according to the bereaved 
family caregivers (11-14), though the evidence is conflicting. The importance of meeting the 
patient and family preferences has been reported to have a strong impact on the actual 
place of death (12). 
 
As family caregivers experience support needs in a number of the mentioned dimensions, it 
has been challenging to find accessible and acceptable interventions that address the range 
of needs (15).  The Carer Support Needs Assessment Tool (CSNAT) is an evidence-based 
and validated tool for the comprehensive assessment of caregivers’ support needs in all the 
domains of end of life care, and it is delivered through a person-centred approach that is led 
by the caregiver but facilitated by the health professional (16-18). The CSNAT is structured 
around 14 broad support domains which fall into two distinct groupings: support that enables 
the family caregiver to care for the care recipient at home (7 domains); and direct support for 
the family caregiver in their caring role (7 domains). The CSNAT Approach provides an 
opportunity to open up a conversation with caregivers, to understand their individual support 
needs and the support they would find helpful. The CSNAT intervention comprises the tool 
integrated into the person-centred approach (16).  
 
Two trials of the CSNAT intervention were conducted in Australia, one in a community 
palliative care setting (described in Box 1) and one in a hospital setting. Results showed a 
significant reduction in caregiver strain during the caregiving period in community palliative 
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care (19) and family caregivers of older people discharged home from hospital were 
significantly more prepared to provide care and reported reduced caregiver strain and 
distress compared to family caregivers in a control group (20). The trial of the CSNAT within 
palliative home care in the UK (21) found a small reduction in early grief, improvements in 
mental and physical health post-bereavement and in the probability of death at home.  
 
Box 1: Brief description of the Australian CSNAT trial in community palliative care   
The overall aim of this trial was to investigate the extent to which a carer assessment tool of 
support needs in end of life home care improves perceived support, carers’ psychological 
and physical wellbeing, caregiver workload, grief and the likelihood of the patients achieving 
their preferred place of death, hence spanning the pre and post bereavement phases.  
 
A stepped wedge cluster design was used to trial the CSNAT intervention in three bases of 
the palliative care service in Western Australia, 2012-14. The outcome measures for the 
intervention and control groups, at the pre-bereavement phase, were caregiver strain and 
distress as measured by the Family Appraisal of Caregiving Questionnaire (FACQ-PC) (22), 
caregiver mental and physical health as measured by SF-12v2 (23), and caregiver workload 
as measured by extent of caregiver assistance with activities of daily living, at baseline and 
follow up. Total recruitment was 620. There was 45% attrition for each group between 
baseline and follow-upmainly due to patient deaths resulting in 322 caregivers completing 
the study (233 in the intervention group and 89 in the control group). At follow-up, the 
intervention group showed significant reduction in caregiver strain relative to controls, 
p=0.018, d=0.348 (95%CI 0.25 to 0.41). Priority support needs identified by caregivers 
included knowing what to expect in the future, having time for yourself in the day and dealing 
with your feelings and worries. The detailed description of the intervention and methodology 
of the pre-bereavement phase is described in Aoun et al (19). There was also positive 
feedback on using the CSNAT from family caregivers (24) and nurses (25).  
 
Brief description of the intervention 
The CSNAT intervention consisted of at least two visits from nurses to caregivers, 2 to 3 
weeks apart, where nurses incorporated the CSNAT into a practitioner facilitated but 
caregiver-led approach to needs assessment and support. Family caregivers identified 
domains where they 
needed more support. This was accomplished by the CSNAT being either self-completed by 
the family caregiver or completed jointly with the nurse. Then a conversation took place to 
determine individual needs and the caregiver’s priorities were discussed with the nurse to 
agree on actions/solutions and a shared action plan. The control group received ‘standard 
practice’ which consisted of the staff meeting with the caregiver during the client visit and 
discussing caregiver needs on an informal and ad-hoc basis that was not documented. 
 
 
This article reports on the second phase of the Australian community palliative care trial 
(described in Box 1), the follow-up at the post-bereavement phase. 
 
OBJECTIVES 
This study investigates the extent to which using the CSNAT intervention during the 
caregiving period has affected bereaved family caregivers’ perceptions of adequacy of 
support, their grief and wellbeing and achievement of their preferred place of death. 
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METHODS 
 
The study was approved by the University Human Research Ethics Committee (HR 24/2011) 
and the Service Human Research Ethics Committee (EC App 068). All caregiver participants 
provided written informed consent to participate in this study and the two ethics committees 
approved this consent procedure.  
 
Data Collection (the caregiver survey) 
All family caregivers who completed the pre-bereavement phase (n=322) were invited to 
take part in a caregiver survey by telephone 4-6 months post-bereavement (2015).  
Demographic information was already available from the pre-bereavement phase of the 
study. Both intervention and control groups completed the following primary and secondary 
outcome measures at post-bereavement: 
 
The primary outcome measure was the perceived adequacy of support provided for the 
caregiver during end of life care which was measured using the fourteen questions of the 
CSNAT domains, revised to the format ‘Did you need more support with’ (responses: 1=no; 
2=a little more; 3=quite a bit more; 4=very much more). These scores were summarised for 
the analysis. The two main groupings of the CSNAT were each summarised and analysed 
separately: The seven domains enabling the caregiver to care for the patient (CSNAT 
Enabling Support domains)  and the seven domains providing more direct support for the 
caregiver’s health and well-being (CSNAT Direct Support domains).  
 
An additional set consisted of three general questions on whether caregivers had been 
asked about their support needs, whether they felt their needs had been listened to, and 
whether there were concerns they had been unable to discuss (responses: 1=always, 
2=usually, 3 =sometimes, 4=never).  
 
There were three secondary outcome measures:   
 
1- Level of grief in bereavement was measured using the Texas Revised Inventory of Grief 
(TRIG) (26). This is a Likert-type measure in two parts. Part 1, comprising eight items, 
measures initial grief at the time of death (TRIG initial). Part 2, with 13 items, assesses 
present grief (TRIG present). It has an internal consistency of 0.77 (Part 1) and 0.86 (Part 2) 
and a reliability of 0.74 (Part 1) and 0.88 (Part 2). A higher grief score indicates a worse 
bereavement outcome. 
 
2- Mental and physical well-being was measured using the SF-12v2 (23). The SF-12v2 
consists of 12 questions relating to: physical health problems, bodily pain, general health 
perceptions, vitality (energy/fatigue), social functioning, role limitations and general mental 
health (psychological distress and psychological well-being). Reliability estimates range from 
0.93 to 0.95. The analysis was undertaken for two scores: the Mental Component Score 
(SF12-MCS) and the Physical Component Score (SF12-PCS) (23). A higher physical or 
mental health score indicates a better outcome. 
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3- A measure of achievement of the preferred place of death was obtained by asking 
whether the actual place of death (home, hospice, hospital, nursing/ residential home, other) 
was the preferred option for the patient (according to the family caregiver, with responses 
yes, no, not discussed) or the preferred option for the family caregiver. The three questions 
were: “Where was the place of death of your loved one?”; “Was that the preferred place of 
death for your loved one?”; “Was that your preferred place of death for your loved one?” A 
congruence analysis was undertaken between actual and preferred place of death for each 
group. 
 
Statistical analyses 
Analysis of the trial was on a per protocol basis. Continuous variables were reported as 
means and standard deviations and categorical variables as frequencies and proportions. 
Differences between groups for continuous variables was determined using independent t 
test, and categorical data using chi square or fishers exact test (when expected cell counts 
<5).  
 
Congruence between preferred and actual place of death was computed as the number of 
patients who died in their preferred locations divided by all patients/caregivers with 
preferences. A difference in proportions was determined using Chi square or Fishers exact 
test.  
 
The primary and secondary outcomes were examined using mixed models accounting for 
the clusters at the three service bases. Linear mixed models were used for the continuous 
data, except for the CSNAT outcomes (direct support, enabling and total) where Tobit 
regression was used due to the floor effect. For questions with ordinal responses, ordered 
logistic regression was used producing proportional odds ratios. For binary data (yes/no) 
logistics regression was used producing odds ratios.  For all models, unadjusted and 
adjusted analysis were produced with the control group coded as 0 and the intervention 
group as 1. Models were adjusted for cluster effect, age of caregiver, gender of caregiver, 
time since death, diagnosis of patient, relationship to care recipient (spouse, child, other) 
and length of palliative care. For the primary outcome, CSNAT, cohen’s d was calculated for 
statistically significant findings.  
 
All data was analysed using Stata 14.1 (27). Statistical significance was considered p<0.05.  
 
 
 
RESULTS 
 
Two thirds of participants in the pre-bereavement phase completed the post-bereavement 
phase of the study (212 out of 322) (Figure 1). Reasons for attrition in the intervention group 
comprised: 28 (12%) patients were still alive at the end date of the project, 9 caregivers (4%) 
declined to participate and 45 (19%) could not be contacted after three attempts or their 
phone line was disconnected. Reasons for attrition were similar for the control group: 4 
patients were still alive (5%), 2 caregivers declined (2%) and 22 were not contactable (25%) 
(Figure 1).  
 
 [Figure 1 about here] 
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Table 1 shows the characteristics of family caregivers who participated in the post-
bereavement study (T3) compared to the larger sample of caregivers who participated in the 
pre-bereavement study (T2). The two groups did not differ on any characteristics.  
 
The only detected difference between the intervention and control groups at the post-
bereavement phase (Table 1) was the higher proportion of ‘non-cancer’ diagnoses in the 
control group and the longer period of palliative care, which is similar to the profile at the pre-
bereavement phase reported in Aoun et al (19).  
 
[Table 1 about here]  
 
Both groups, when asked in which areas they would have liked more help and support for 
themselves, predominantly reported “having time to yourself in the day”, followed by 
“knowing what to expect in the future” (Figure 2). The unmet needs of the control group were 
more pronounced than the intervention group in most domains. In particular, the two areas in 
the enabling care grouping with significant differences (greater unmet need for the control 
group compared to the intervention group) were “understanding your relative’s illness” 
(p=0.026) and “knowing who to contact if concerned” (p=0.028). 
 
[Figure 2 about here] 
 
The summary statistics for the primary and secondary outcomes are shown in Table 2. 
Lower mean scores are noted for the intervention group on the CSNAT (enabling, direct and 
total), indicating lower unmet need. Similar distribution of responses was seen for ‘feeling 
listened to’ and ‘being asked about support needs’. There was a greater proportion of 
caregivers in the intervention group who felt that ‘sometimes’ they were unable to discuss 
their concerns. The regression analysis supported this finding with a reduced odds of being 
able to discuss concerns (OR 0.30: 95% CI 0.1 to 0.5, p<0.001) (Table 3). Responses to the 
question :”Which support needs were you unable to discuss with the nurses and why was 
this?” revealed that the majority of the family caregivers with the “sometimes” response 
(69%) was reporting constraint due to the presence of the care recipient, be it mother, father, 
sister and mainly husband. The following caregiver’s comment describes this situation: 
“Difficult to bring up when he was in the room. I would phone the nurses later and I would 
email his doctor” (ID 109). 
 
 [Table 2 about here] 
 
Table 3 outlines the unadjusted and adjusted analysis for primary and secondary outcomes. 
The CSNAT enabling and total scores demonstrated statistically significant differences 
between the groups. The intervention group scored on average 2.2 points (95% CI: -2.9, -
1.4) less on the CSNAT enabling domains compared to the controls, indicating lower unmet 
need with a moderate effect size (cohen’s d=0.43). For the CSNAT total score, the 
intervention group scored on average 2.9 points (95% CI: -3.7, -2.1) less compared to the 
control, with a small to moderate effect size (cohen’s d = 0.33). There was no difference 
between the two groups in the direct support grouping. There were no significant differences 
in the initial and present grief levels or for MCS and PCS scores for the two groups.  
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[Table 3 about here]  
 
Table 4 presents the actual and preferred place of death for the patient (according to their 
family caregiver) and the caregiver preferred place of death for their care recipients. The 
actual place of death did not significantly differ between the two groups, though more of the 
intervention group died at home (55.9%) compared to 48.3% in the control group. 
Congruence between patients’ preferred and actual place of death as reported by their 
caregiver was 79.6% for the intervention group compared to 63.3% for the control group, 
meaning that significantly more in the intervention group could achieve their preferred place 
of death (p=0.034). There was no significant difference in such congruence for family 
caregivers. The preferred place of death was agreed upon more often between patient and 
caregiver in the intervention group compared to the control (93.8% vs 83.0% respectively, 
p=0.020). A small number of respondents did not complete the questions on preferences, 
either because they were distressed or because the caregivers did not know of their care 
recipients’ preferences. There was a significant difference in the bereavement period (time 
since death) between the two groups (a mean difference of 2.8 weeks) with controls having 
had a longer time since death. 
 
[Table 4 about here] 
 
DISCUSSION  
 
A considerable proportion of family caregivers who completed the intervention pre-
bereavement responded to the post-bereavement survey (66%) with the attrition rate being 
mainly due to patients not having died before the end of the project (10%), and also due to 
caregivers being uncontactable (some with disconnected phone lines) having moved on or 
moved away after the death (21%).  However, very few caregivers declined to participate 
(3%). This good response rate is consistent with the one obtained for the feedback interview 
at the pre-bereavement phase of the study (24). On the whole, the total sample and the 
intervention and control groups at post bereavement were representative of the pre-
bereavement total sample and its two groups. It is worth noting that the interview style used 
pre and post bereavement in this study may have contributed to the good response rate by 
facilitating the creation of relationships between participants and the research nurse that 
fostered respect, trust, and concern, such advantages being reported in the literature (28, 
29).  
 
The majority of the intervention effect estimates on outcomes (7 out of 10) were in a 
favourable direction even though not always reaching statistical significance (Table 3). There 
was a significant difference in perception of support needs being better met for the 
intervention group (CSNAT total) and more particularly for domains in the enabling care 
grouping (p<0.001, d=0.43) which means the support that enables the family caregiver to 
care for the patient at home, rather than the more direct personal support for the caregiver. 
Within the enabling care grouping, three items were particularly better achieved for the 
intervention group “understanding your relative’s illness” (p=0.026), “knowing who to contact 
if concerned” (p=0.028) and to a lesser extent “managing your relative’s symptoms” 
(p=0.052). Reducing such uncertainty by targeting the specific support and information 
needs of caregivers through open and frequent communication with their health care 
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provider (as afforded by the CSNAT Approach) is reported to allow family caregivers to more 
fully prepare for the death (7,8). The finding that more of the intervention group felt that 
“sometimes” they could not discuss their concerns with the nurses, albeit because they felt 
they did not want to discuss them in the presence of their care recipients, is a reflection of 
the more comprehensive nature of the CSNAT compared to standard practice. The CSNAT 
identified the legitimate caregiver concerns and encouraged the discussion but not all 
caregivers wished to conduct the discussion in front of the patient.  This raises a training 
issue for practitioners where it may be necessary to give caregivers the option of completing 
the CSNAT on their own and then make a separate contact to have the CSNAT conversation 
with them.  
 
The fact that the intervention group reported that more of their needs have been met is 
consistent with them experiencing less strain than the control group during the pre-
bereavement period (19). The fact that this support was significant in the enabling care 
grouping of the CSNAT is also in line with the nurses’ feedback during the caregiving period 
(25), where a higher percentage of nurses (77%) indicated that ‘enabling care’ was within 
the service’s capacity, whereas a lesser proportion of nurses (56%) felt they could action 
‘direct’ personal support for the caregivers themselves. The authors explained that this 
difference in nurses’ responses may be due to the existing and necessary focus of service 
providers’ resources on patient care delivery and support that the service routinely provides 
(25). While it is an important finding that caregivers felt supported delivering care to their 
relative, nevertheless it is an indication that the service focus has not shifted enough towards 
the direct support needs of the caregivers. It may also be the case that the nurses saw the 
enabling domains as delivering their usual patient-focussed care (equipment , 
medications….) but they did not distinguish between the needs of the caregivers within these 
domains and those of the patients. 
In both groups,  nearly one half or more died at home, and in particular this was 55.9% for 
the intervention group, which is consistent with the palliative care service proportion of home 
deaths, reported as 56.8% for people who have family caregivers (30). More patients in the 
intervention group, compared to the control group, achieved their preference for place of 
death according to their family caregivers (79.6% vs 63.3%, p=0.034). This congruence rate 
is at the upper end of those reported in the literature 30-90% (31). However, home may not 
be the ideal or the preferred location for dying for many patients (14, 32). Aoun and Skett 
emphasized that “the ability to die in the place of choice needs to be looked at as a possible 
indicator of meeting patient needs or as a quality measure in end-of life care” (32, p.534).  
One proposed explanation put forward for the high agreement rates between patients’ and 
caregivers’ preference about the place of death is that they could be due to the opportunity 
of the conversation that CSNAT has systematically provided. Nurses have mentioned 
undertaking discussions with caregivers which consisted of “what to expect as [client’s] 
condition deteriorates and death nears”, and “long talk about end of life care/dying at home” 
(19, p.11). This may have prepared caregivers for the imminent death, a concept being 
emphasized in the literature as protective against adverse outcomes in the post 
bereavement period (7, 8, 10). The importance of early conversations about preferences for 
place of death involving patients and their families in order to achieve the preferred place 
has been highlighted in the literature (12). 
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There was also a significant greater agreement in the intervention group between the 
caregivers and their care recipients on the preferred place of death (93.8% vs 83%, p=0.02) 
in this study. Grande & Ewing (33) reported that death in the preferred location was more 
likely if the patient and caregiver agreed. Therefore a higher likelihood of dying in place of 
preference in the intervention arm may be a result of higher level of agreement, rather than 
perhaps the intervention itself. 
The post-bereavement outcomes differed between this study and the UK post-bereavement 
study (21). The UK study reported a small reduction in early grief, improvements in mental 
and physical health and probability of death at home, but no indication that the intervention 
group was more likely to feel their needs had been met. The UK trial also had a considerably 
larger sample size (n=681) and therefore higher statistical power than in our study. However, 
the authors stated that the low implementation rate of the CSNAT by the services during the 
caregiving phase and subsequently the low response rate by bereaved caregivers to the 
postal surveys have reduced the potential of the intervention to make an impact (21). Also 
the use of intention-to-treat analysis, where not all participants received the intervention, 
may have diluted the intervention effect. 
 
Though not significant, the differences in the SF-12 scores of MCS and PCS in our study 
were consistent with the pre-bereavement profiles, where the control group had better 
mental scores, and the intervention group had better physical scores (19). Compared to the 
UK study, this group had similar PCS scores but better MCS scores (21), perhaps meaning 
that their mental health was less compromised. In this study, the intervention had no impact 
on grief, but this study group had lower initial and present grief levels than the UK group, 
possibly due to their better mental health impacting positively on their grief. Garrido et al (34) 
have shown that, among other outcomes, better quality of death and better caregiver mental 
health before the patient’s death were predictors of improved caregiver bereavement 
adjustment. 
 
The fact that Nielsen et al (6) found that the levels of grief and depressive symptoms were 
higher during caregiving than six months after the loss, and the fact that our study found that 
caregivers experienced less strain pre-death due to the intervention (19), and that at post-
death they felt their needs have been met and achieved the patient preferred place of death, 
reinforces the need for palliative care services to take action during the pre-bereavement 
period to effectively support family caregivers. Yet the ‘window of opportunity’ for contact 
with caregivers to assess their grief and bereavement needs while heading to the care 
recipient’s impending death is still not well utilised in the palliative care system (35). Seizing 
this opportunity pre-bereavement is even more crucial that the latest findings from the 
Australian bereavement support survey showed that just half of the bereaved had a follow up 
contact from the palliative care services at 3-6 weeks, and only a quarter had a follow-up at 
6 months, and that the blanket approach to bereavement support adopted by the services 
was deemed unhelpful (36). While in general, there is a lack of evidence which could guide 
pre-death risk identification and interventions that could benefit informal caregivers before 
and after the death of their care recipient (35), the results from this study provide the 
evidence that the CSNAT intervention has a positive impact on family caregivers post-
bereavement. 
 
Limitations 
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The main analysis in this study was based on per protocol analysis, in line with the pre-
bereavement trial. Per protocol analyses may have boosted the likelihood that the 
intervention had an effect as it only included those who actually received the intervention. 
However, statistical comparisons were undertaken for participants who withdrew from the 
intervention and the control groups and there were no significant differences with those who 
completed the study. Table 1 demonstrates that the characteristics of family caregivers were 
similar in the two phases and there were no characteristics that appeared to influence 
withdrawal. 
Restricting the time since death to 4-6 months for the post-bereavement interviews reduces 
the likelihood of recall bias and has produced adequate response rates as reported in the 
literature (21, 37). May be a longer term follow-up of six months or more could have 
captured those who developed complicated grief and thus produced more group differences. 
However, it is likely that the sample size would have been much smaller with lower statistical 
power to show such group differences. 
Another limitation is that all the preferences for place of death have come from caregiver 
interviews collected post bereavement. Certainly a prospective measure would have been 
better to elicit preferences that are provided directly by the patient rather than by proxy from 
the caregiver. However the end result is about the caregiver feeling good about the patient 
achieving what they have thought would be their preference. 
 
As reported in the pre-bereavement phase of the study (19), the issue of unbalanced groups 
ultimately is an inherent limitation of the stepped-wedge design; however, the generalized 
linear mixed modelling (GLMM) used to examine the efficacy of the CSNAT intervention is 
generally robust to unbalanced groups. Relatedly, the intervention and control groups in both 
the pre and post bereavement phases were found significantly different on a number of 
baseline characteristics. While analyses were adjusted for these differences, other potential 
underlying biases cannot be completely ruled out. 
 
Conclusions 
The positive supportive outcomes from the CSNAT trials demonstrated the benefits gained 
by both family caregivers and health care providers in engaging caregivers in early and 
direct assessment of their support needs pre-bereavement. Therefore, there is a need for 
palliative care services to consider the continuum of the pre and post bereavement phases, 
the predictors of bereavement outcome among caregivers during caregiving, and to develop 
strategies that assist caregivers in feeling more prepared for the death and their 
bereavement. However, all this will not be achieved until services are funded to enable them 
to fully adhere to their remit or ethos of being there for the family caregivers as well as the 
patients and thus be able to incorporate systematic assessment and support of family 
caregivers. 
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Table 1: Comparison of characteristics of family caregivers who participated in the CSNAT pre- and post-bereavement phases. 
Caregiver 
[profile 
 
Pre bereavement 
T2 
Post bereavement 
T3 
Total pre 
bereavement 
Total post 
bereavement 
 
 Interventi
on 
n (%) 
Control 
n (%) 
 
p value* 
 
Interventio
n 
n (%) 
Control 
n (%) 
 
p value* 
 
T2 T3 p value * T2 vs T3 
Total  n=233 n=89  n=152 n=60  n=322 n=212  
Age Mean (SD) 62.1 (0.8) 65.5 (1.4) 0.030 T 63.7 (11.8) 67.1 (11.7) 0.063 T 63 (12.7) 64.6 (11.8) 0.144 T 
 
Gender Male 69 (29.6) 18 (20.2) 0.090 42 (27.6) 10 (16.7) 0.095 87 (27) 52 (24.5) 0.521 Female 164 (70.4) 71 (79.8) 110 (72.4) 50 (83.3) 235 (73) 160 (75.5) 
Marital  Never married 13 (5.6) 2 (2.2) 
0.217 F 
8 (5.3) 1 (1.7) 
0.190 F 
15 (4.7) 9 (4.2) 
0.881 status Widowed 7 (3.0) 2 (2.2) 6 (3.9) 2 (3.3) 9 (2.8) 8 (3.8) Divorced/ Separated 11 (4.7) 9 (10.1) 5 (3.3) 6 (10.0) 20 (6.2) 11 (5.2) 
Married/ Defacto 202 (86.7) 76 (85.4) 133 (87.5) 51 (85.0) 278 (86.3) 184 (86.8) 
Education No formal education 1 (0.4) 0 (0) 
0.689 F 
1 (0.7) 0 (0) 
0.322 F 
1 (0.3) 0 (0) 
0.654 F Primary 5 (2.1) 1 (1.1) 5 (3.3) 1 (1.7) 6 (1.9) 7 (3.3) Secondary 133 (57.1) 57 (64.0) 85 (55.9) 41 (68.3) 190 (59) 126 (59.4) 
Tertiary/  Trade 94 (40.3) 31 (34.8) 61 (40.1) 18 (30) 125 (38.8) 79 (37.3) 
Culture Australian 12 (55.4) 60 (67.4) 
0.103 
91 (59.9) 40 (66.7) 
0.231 F 
189 (58.7) 131 (61.8) 
0.775 Other English speaking 66 (28.3) 21 (23.6) 37 (24.3) 16 (26.7) 87 (27) 53 (25) 
Non-English speaking 38 (16.3) 8 (9.0) 24 (15.8) 4 (6.7) 46 (14.3) 28 (13.2) 
Relationship  Spouse 15 (67.4) 63 (70.8) 
0.644 F 
102 (67.8) 43 (70) 
0.545 F 
220 (68.3) 145 (68.4) 
0.979 F 
to care  Parent 4 (1.7) 3 (3.4) 2 (1.3) 2 (3.3) 7 (2.2) 4 (1.9) 
recipient Child 52 (22.3) 16 (18.0) 37 (24.3) 11 (18.3) 68 (21.1) 48 (22.6) 
Sibling 5 (2.2) 3 (3.4) 2 (1.3) 2 (3.3) 8 (2.5) 4 (1.9) 
Other 15 (6.4) 4 (4.5) 8 (5.3) 3 (5) 19 (5.9) 11 (5.2) 
Diagnosis Cancer 17 (75.1) 66 (74.2) 
0.026 
109 (71.7) 43 (71.7) 
0.028 F 
241 (74.8) 152 (71.7) 
0.713 Cancer & non-cancer 39 (16.7) 8 (9.0) 29 (19.1) 5 (8.3) 47 (14.6) 34 (16) 
Non-cancer 19 (8.2) 15 (16.8) 14 (9.2) 12 (20) 34 (10.6) 26 (12.3) 
Length of 
palliative 
care in 
months,  
Mean (SD) 2.9 (0.3) 6.0 (0.88) <0.001 T 3 (4.5) 6.3 (9.7) 0.001 T 3.8 (-5.8) 3.9 (-6.6) 0.854 T 
*Chi-squared unless otherwise specified. T, t-test of means; F, Fishers exact test. 
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Table 2: Summary data for post-bereavement outcomes (T3) 
 Intervention Control 
Variables total n mean (SD) total n mean (SD) 
CSNAT Enabling domains 147 7.6 (1.3) 56 8.5 (3.2) 
CSNAT Direct Support domains 147 7.9 (1.8) 56 8.4 (3.3) 
All CSNAT domains (Total) 147 15.6 (2.7) 56 16.9 (6.4) 
TRIG initial 147 20.6 (7.9) 58 18.6 (6.4) 
TRIG present 148 42.8 (10.5) 56 42.1 (11.5) 
SF-12 MCS 151 47.0 (10.5) 60 49.3 (10.9) 
SF-12 PCS 151 50.6 (10.2) 60 48.7 (10.3) 
     
Perceived adequacy of support total n n (%) total n n (%) 
Nurses asked about your support needs  
   never 
   sometimes 
   usually  
   always  
   don’t know 
149 
 
2 (1.3) 
19 (12.8) 
30 (20.1) 
97 (65.1) 
1 (0.7) 
56 
 
1 (1.8) 
8 (14.3) 
11 (19.6) 
34 (60.7) 
2 (3.6) 
Nurses listened to any concerns you had 
   never 
   sometimes 
   usually  
   always  
   don’t know 
149 
 
0 (0) 
10 (6.7) 
20 (13.4) 
119 (79.9) 
0 (0) 
54 
 
1 (1.8) 
4 (7.4) 
8 (14.8) 
41 (75.9) 
0 (0) 
Unable to discuss any concerns with nurses 
   always 
   usually 
   sometimes 
   never 
   don’t know 
149 
 
3 (2.0) 
1 (0.7) 
16 (10.7) 
126 (84.6) 
3 (2.0) 
56 
 
2 (3.6) 
0 (0) 
1 (1.8) 
53 (94.6) 
0 (0) 
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Table 3: Estimate of effect of intervention in the post-bereavement phase (control=0, intervention=1) 
 Unadjusted Analysis Adjusted Analysis 
 
Variable Intervention Effect 
unadjusted difference 
(95% confidence intervals) 
p value Intervention Effect 
adjusted difference* 
(95% confidence intervals) 
p-value Favourable 
result 
Estimate of effect of intervention from linear mixed effects models, accounting for cluster effect of base. Intervention effect indicates 
differences in scores between the control and intervention groups (control=0, intervention=1) 
CSNAT Enabling Support domains To  -2.2 (-3.3, -1.2) <0.001 -2.2 (-2.9, -1.4)  <0.001 <0 
CSNAT Direct Support domains To -0.9 (-2.3, 0.5) 0.228 -0.8 (-0.1, 0.04)  0.372 <0 
All CSNAT domains (Total) To -2.8 (-3.4, 2.3) <0.001 -2.9 (-3.7, -2.1) <0.001 <0 
TRIG initial 2.0 (-0.3, 4.3) 0.085 1.2 (-1.2, 3.7) 0.325 <0 
TRIG present 0.8 (-2.4, 4.1) 0.615 -0.6 (-4.1, 2.8) 0.713 <0 
SF-12 MCS -2.4 (-5.1, 0.8) 0.146 -1.7 (-5.1, 1.7) 0.319 >0 
SF-12 PCS 1.9 (-1.1, 5.0) 0.212 1.3 (-2.0, 4.5) 0.451 >0 
Perceived Adequacy of Support. Estimate of effect of intervention (proportional OR) on ordinal response outcomes  
Nurses asked about your support needs 1.2 (0.8, 1.6) 0.689 1.0 (0.4, 2.4) 0.970 >1 
Nurses listened to any concerns you had 1.3 (0.9, 1.8) 0.174 1.1 (0.6, 1.9) 0.829 >1 
Unable to discuss any concerns with nurses 0.4 (0.2, 0.6) <0.001 0.3 (0.1, 0.5) <0.001 >1 
 
* Mixed-effects models provided estimates of the mean adjusted difference. Adjusted for cluster effect, age of caregiver, gender of caregiver, time since death, diagnosis of 
patient, relationship to cared person (spouse, child, other) and length of palliative care.  
 
To
 Tobit regression used for CSNAT due to floor effects. 
Intracluster correlation (ICC) for the bases (clusters) were essentially zero meaning that there was no correlation of outcome within each base. 
Cohen’s d=0.33 (0.02, 0.64) for CSNAT Total, and Cohen’s d=0.43 (0.12, 0.74) for CSNAT Enabling Support. 
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Table 4: Comparison in actual and preferred place of death between the two groups  
 
 
Intervention 
n=152 
Control 
n=60 
Two group 
comparison, p-value* 
 
 n % n % 
Bereavement period 
(Time since death in 
weeks) 
 
Mean (SD) 
 
23.5 (8.2) 26.3 (8.2) 
 
0.032 T 
Actual place of death Home 85 55.9 29 48.3 0.318 
 Hospital 15 9.9 8 13.3 0.322 F1 
 Hospice 43 28.3 22 36.7  
 Nursing home 8 5.2 1 1.7  
 Other 1 0.7 0 0  
 
      
Actual place of death Home 85 55.9 29 48.3 0.318 
(Recoded) Elsewhere 67 44.1 31 51.7  
      
 
Achievement of 
preference for place 
of death  
(patient preference is 
reported by 
caregiver) 
Patient preference vs actual 
 
Achieved 
Not achieved 
Too distressed/not discussed  
 
 
121 
24 
7 
 
 
79.6 
15.8 
4.6 
 
 
38 
15 
7 
 
 
63.3 
25.0 
11.7 
 
 
0.034  
 Caregiver preference vs actual 
 
Achieved 
Not achieved 
Too distressed/not discussed  
 
125 
24 
3 
 
 
82.2 
15.8 
2.0 
 
 
46 
9 
5 
 
76.7 
15.0 
8.3 
 
 
0.110 
 
 Patient preference vs 
Caregiver preference 
 
Agreed 
Disagreed 
 
 
 
136 
9 
 
 
 
93.8 
6.2 
 
 
 
44 
9 
 
 
 
83.0 
17.0 
 
 
 
0.020    
       
*Chi-squared unless otherwise specified. T, t-test of means. F1, Fishers exact test using the four groupings of Home/Hospital/Hospice/all-others.  
Congruence analysis based on data for preferred location for 198 patients and 204 caregivers 
 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
5 
 
 
Figure 1: Flowchart of participants between the pre-bereavement and post-bereavement phases 
 
Figure 2: Comparison of unmet support needs for the intervention and control groups at the post-bereavement phase 
(More help needed classified as a response of “A little more”, “Quite a bit more” or “Very much more”) 
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